YMRC
GDRX icon

Yorktown Management & Research Company’s GoodRx Holdings GDRX Stock Holding History

Yorktown Management & Research Company’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,200
Closed -$104K – 200
2022
Q3 		$104K Buy
+22,200
New +$140K 0.13% 190

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Yorktown Management & Research Company's GDRX Position: Q4 2022 in Review

Yorktown Management & Research Company sold out of GoodRx Holdings (GDRX) in Q4 2022, closing a stake of 22,200 shares — an estimated $104K sold.

Yorktown Management & Research Company first reported a position in GDRX in Q3 2022 and held it in 1 quarter. The position peaked at $104K in Q3 2022. 160 funds tracked by Wall St. Rank hold GDRX as of Q4 2022.

  • Yorktown Management & Research Company reported no remaining GoodRx Holdings position as of Q4 2022 after selling out during the quarter.
  • Yorktown Management & Research Company sold 22,200 GoodRx Holdings shares in Q4 2022, an estimated $104K.
  • Yorktown Management & Research Company first reported a position in GoodRx Holdings in Q3 2022 and held it in 1 quarter.
  • Yorktown Management & Research Company's GoodRx Holdings position peaked at $104K in Q3 2022.
  • 160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2022.

Based on Yorktown Management & Research Company's 13F filing for Q4 2022, filed 26 Jan 2023.